Clinical Trial Update: A Study to Evaluate the Effects of ONO-2506 Intravenous Infusion in Patients With Acute Ischemic Stroke [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating ONO-2506 intravenous infusion in acute ischemic stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• ONO-2506

Snippet

Sponsor: Ono Pharma USA Inc | Conditions: Cerebrovascular Accident | Phase 2, Phase 3 | Status: TERMINATED